tiprankstipranks
Trending News
More News >
Opus Genetics (IRD)
NASDAQ:IRD

Opus Genetics (IRD) Revenue

Compare
1,031 Followers

Opus Genetics Revenue

Opus Genetics had a revenue of 4.30M in the quarter ending Dec 31, 2024, with 11.25%. This bring the company's revenue in the last twelve months to 10.99M, Decreased 31.15%. In the fiscal year ending Dec 31, 2024, Opus Genetics had annual revenue of 10.99M with -42.30% growth.
Revenue (ttm)
10.99M
Revenue Growth
-42.30%
P/S Ratio
5.26
Revenue/Employee
$610,667
Employees
18
Market Cap
$57.87M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
10.99M-8.06M-42.30%
Dec 31, 2023
19.05M-20.80M-52.20%
Dec 31, 2022
39.85M39.26M+6,665.70%
Dec 31, 2021
589.00K+∞%
Dec 31, 2020
0.00
Dec 31, 2019
0.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis